Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.

Cancer cell | 2017

Constitutive activation of Gαq signaling by mutations in GNAQ or GNA11 occurs in over 80% of uveal melanomas (UMs) and activates MAPK. Protein kinase C (PKC) has been implicated as a link, but the mechanistic details remained unclear. We identified PKC δ and ɛ as required and sufficient to activate MAPK in GNAQ mutant melanomas. MAPK activation depends on Ras and is caused by RasGRP3, which is significantly and selectively overexpressed in response to GNAQ/11 mutation in UM. RasGRP3 activation occurs via PKC δ- and ɛ-dependent phosphorylation and PKC-independent, DAG-mediated membrane recruitment, possibly explaining the limited effect of PKC inhibitors to durably suppress MAPK in UM. The findings nominate RasGRP3 as a therapeutic target for cancers driven by oncogenic GNAQ/11.

Pubmed ID: 28486107 RIS Download

Additional research tools detected in this publication

Antibodies used in this publication

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: P01 AI091580
  • Agency: NCI NIH HHS, United States
    Id: R01 CA142873
  • Agency: NCI NIH HHS, United States
    Id: U54 CA143874

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


cBioPortal (tool)

RRID:SCR_014555

A portal that provides visualization, analysis and download of large-scale cancer genomics data sets.

View all literature mentions

YAP (D8H1X) XP Rabbit mAb (antibody)

RRID:AB_2650491

This recombinant monoclonal targets YAP

View all literature mentions

RASGRP3 (phospho T133) antibody [EPNCIR148] (antibody)

RRID:AB_11128345

This monoclonal targets RASGRP3 (phospho T133) antibody [EPNCIR148]

View all literature mentions

RASGRP 4 antibody (antibody)

RRID:AB_10697912

This polyclonal targets RASGRP 4 antibody

View all literature mentions

RASGRP2 antibody (antibody)

RRID:AB_10640790

This polyclonal targets RASGRP2 antibody

View all literature mentions

Rsk1 Phospho (pT359/pS363) (antibody)

RRID:AB_562342

This monoclonal targets Human Rsk1, phospho (Thr359 / Ser363)

View all literature mentions

Raf-B (C-19) (antibody)

RRID:AB_630938

This polyclonal targets Raf-B (C-19)

View all literature mentions

H-Ras (C-20) (antibody)

RRID:AB_631670

This polyclonal targets HRAS

View all literature mentions

K-Ras (F234) (antibody)

RRID:AB_627865

This monoclonal targets KRAS

View all literature mentions

N-Ras (F155) (antibody)

RRID:AB_628041

This monoclonal targets NRAS

View all literature mentions

ERK 2 (C-14) (antibody)

RRID:AB_2141292

This monoclonal targets ERK 2

View all literature mentions

Galpha q (E-17) (antibody)

RRID:AB_631536

This polyclonal targets GNAQ

View all literature mentions

RasGRP3 (C33A3) Rabbit mAb (antibody)

RRID:AB_2269292

This monoclonal targets RasGRP3

View all literature mentions

Myc-Tag (9B11) Mouse mAb (antibody)

RRID:AB_331783

This monoclonal targets c-Myc

View all literature mentions

Met Antibody (antibody)

RRID:AB_331361

This monoclonal targets Met

View all literature mentions

Cleaved PARP (Asp214) Antibody (Human Specific) (antibody)

RRID:AB_331426

This polyclonal targets Cleaved PARP (Asp214) (Human Specific)

View all literature mentions

PARP Antibody (antibody)

RRID:AB_2160739

This polyclonal targets PARP

View all literature mentions

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb (antibody)

RRID:AB_2315112

This monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)

View all literature mentions

Phospho-MEK1/2 (Ser217/221) Antibody (antibody)

RRID:AB_331648

This polyclonal targets Phospho-MEK1/2 (Ser217/221)

View all literature mentions

PKC beta II (antibody)

RRID:AB_562197

This monoclonal targets PKCbetaII

View all literature mentions

PKC delta (C-20) (antibody)

RRID:AB_632229

This polyclonal targets PRKCD

View all literature mentions

PKC betaII (C-18) (antibody)

RRID:AB_2252825

This polyclonal targets PRKCB

View all literature mentions

PKC betaI Antibody (C-16) (antibody)

RRID:AB_2168968

This polyclonal targets Prkcb

View all literature mentions

Mouse Anti-Human PRKCH MaxPab?? Polyclonal Antibody, Unconjugated (antibody)

RRID:AB_1018609

This polyclonal targets PRKCH MaxPab mouse polyclonal antibody (B02)

View all literature mentions

PKCzeta (C24E6) Rabbit Antibody (antibody)

RRID:AB_10693777

This monoclonal targets PKCzeta

View all literature mentions

PKCα Antibody (antibody)

RRID:AB_2284227

This polyclonal targets PKCα

View all literature mentions

J:NU (organism)

RRID:IMSR_JAX:007850

Mus musculus with name J:NU from IMSR.

View all literature mentions

Ramos (cell line)

RRID:CVCL_0597

Cell line Ramos is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions